McCormick P - Search Results

1

Antiparkinson concentrations of pramipexole and PHNO occupy dopamine D2(high) and D3(high) receptors.

Seeman P, Ko F, Willeit M, McCormick P, Ginovart N. Seeman P, et al. Among authors: mccormick p. Synapse. 2005 Nov;58(2):122-8. doi: 10.1002/syn.20193. Synapse. 2005. PMID: 16088951

2

Increased dopamine D2(High) receptors in amphetamine-sensitized rats, measured by the agonist [(3)H](+)PHNO.

Seeman P, McCormick PN, Kapur S. Seeman P, et al. Among authors: mccormick pn. Synapse. 2007 May;61(5):263-7. doi: 10.1002/syn.20367. Synapse. 2007. PMID: 17318886

3

Dopamine D2 receptor radiotracers [(11)C](+)-PHNO and [(3)H]raclopride are indistinguishably inhibited by D2 agonists and antagonists ex vivo.

McCormick PN, Kapur S, Seeman P, Wilson AA. McCormick PN, et al. Nucl Med Biol. 2008 Jan;35(1):11-7. doi: 10.1016/j.nucmedbio.2007.08.005. Epub 2007 Nov 19. Nucl Med Biol. 2008. PMID: 18158938

4

Isoflurane anaesthesia differentially affects the amphetamine sensitivity of agonist and antagonist D2/D3 positron emission tomography radiotracers: implications for in vivo imaging of dopamine release.

McCormick PN, Ginovart N, Wilson AA. McCormick PN, et al. Mol Imaging Biol. 2011 Aug;13(4):737-46. doi: 10.1007/s11307-010-0380-3. Mol Imaging Biol. 2011. PMID: 20680481

5

Radiosynthesis and evaluation of [11C]-(+)-4-propyl-3,4,4a,5,6,10b-hexahydro-2H-naphtho[1,2-b][1,4]oxazin-9-ol as a potential radiotracer for in vivo imaging of the dopamine D2 high-affinity state with positron emission tomography.

Wilson AA, McCormick P, Kapur S, Willeit M, Garcia A, Hussey D, Houle S, Seeman P, Ginovart N. Wilson AA, et al. Among authors: mccormick p. J Med Chem. 2005 Jun 16;48(12):4153-60. doi: 10.1021/jm050155n. J Med Chem. 2005. PMID: 15943487

6

Radiosynthesis, ex vivo and in vivo evaluation of [11C]preclamol as a partial dopamine D2 agonist radioligand for positron emission tomography.

Vasdev N, Natesan S, Galineau L, Garcia A, Stableford WT, McCormick P, Seeman P, Houle S, Wilson AA. Vasdev N, et al. Among authors: mccormick p. Synapse. 2006 Sep 15;60(4):314-8. doi: 10.1002/syn.20304. Synapse. 2006. PMID: 16786538

7

Ex vivo [11C]-(+)-PHNO binding is unchanged in animal models displaying increased high-affinity states of the D2 receptor in vitro.

McCormick PN, Kapur S, Reckless G, Wilson AA. McCormick PN, et al. Synapse. 2009 Nov;63(11):998-1009. doi: 10.1002/syn.20671. Synapse. 2009. PMID: 19598174

8

In vivo quantification of regional dopamine-D3 receptor binding potential of (+)-PHNO: Studies in non-human primates and transgenic mice.

Rabiner EA, Slifstein M, Nobrega J, Plisson C, Huiban M, Raymond R, Diwan M, Wilson AA, McCormick P, Gentile G, Gunn RN, Laruelle MA. Rabiner EA, et al. Among authors: mccormick p. Synapse. 2009 Sep;63(9):782-93. doi: 10.1002/syn.20658. Synapse. 2009. PMID: 19489048

9

Acutely administered antipsychotic drugs are highly selective for dopamine D2 over D3 receptors.

McCormick PN, Wilson VS, Wilson AA, Remington GJ. McCormick PN, et al. Pharmacol Res. 2013 Apr;70(1):66-71. doi: 10.1016/j.phrs.2013.01.002. Epub 2013 Jan 14. Pharmacol Res. 2013. PMID: 23327779

10

Low dose pramipexole causes D3 receptor-independent reduction of locomotion and responding for a conditioned reinforcer.

McCormick PN, Fletcher PJ, Wilson VS, Browne JD, Nobrega JN, Remington GJ. McCormick PN, et al. Neuropharmacology. 2015 Feb;89:225-31. doi: 10.1016/j.neuropharm.2014.09.026. Epub 2014 Oct 13. Neuropharmacology. 2015. PMID: 25283483

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

698 results

Search Page

Filters